重大事件即時報告 8-K 2026-06-25

報告日期：2026年6月18日

AI 繁中摘要

📋 **申報類型：8-K**  
**公司：eHealth, Inc.（股票代碼：EHTH）**  
**報告日期：2026年6月18日**

eHealth, Inc. 於2026年6月18日舉行年度股東大會，會上通過多項重要決議，現重點整理如下：

**1️⃣ 董事選舉（第二類董事）**  
股東投票通過選出兩位任期三年的董事：  
- **Prama Bhatt**：贊成18,471,633票 / 反對2,729,748票  
- **Beth A. Brooke**：贊成17,453,021票 / 反對3,748,360票  

**2️⃣ 委任核數師**  
通過委任 **Ernst & Young LLP** 為截至2026年12月31日止財政年度的獨立註冊會計師事務所，投票結果：贊成28,357,141票 / 反對43,017票 / 棄權1,516,636票。

**3️⃣ 諮詢性高管薪酬投票**  
股東以諮詢方式批准公司指定高管的薪酬安排，結果：贊成18,199,238票 / 反對1,375,703票 / 棄權1,626,440票，另有8,715,413票為經紀商未投票。

**4️⃣ 修訂2024年股權激勵計劃**  
通過修訂及重列「2024年股權激勵計劃（經修訂及重列）」，額外增加 **1,300,000股** 普通股作為未來發行上限。投票結果：贊成16,122,573票 / 反對3,457,022票 / 棄權1,621,786票，經紀商未投票8,715,413票。

**📊 股東出席情況**  
截至記錄日（2026年4月20日），公司總投票權為 **35,958,616票**（包括31,532,924股普通股及2,250,000股A系列優先股對應的4,425,692票）。股東大會出席率達 **83.19%**（29,916,794票）。

**💡 對投資者的潛在影響**  
- 本次擴大股權激勵計劃將使管理層及員工獲得更多股權激勵，有助於留住人才及提升長期表現，但同時可能導致每股盈利被攤薄。  
- 高管薪酬獲得諮詢性通過，反映股東對現有薪酬結構的認同。  
- 董事會選舉結果顯示股東支持現有治理方向，公司營運穩定性預期不變。

（全文完）

展開英文正文

ehth-20260618FALSE000133349300013334932026-06-182026-06-18

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (date of earliest event reported): June 18, 2026
EHEALTH, INC.
(Exact Name of Registrant as Specified in its Charter)

Delaware001-3307156-2357876
(State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification No.)

9190 PRIORITY WAY WEST DR., SUITE 110
INDIANAPOLIS, IN 46240
 (Address of principal executive offices)    (Zip Code)

(737) 248-2340
(Registrant’s telephone number, including area code)

Not applicable
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.001 per shareEHTHThe Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(e) Approval of an amendment and restatement of the eHealth, Inc. Amended and Restated 2024 Equity Incentive Plan

On June 18, 2026, eHealth, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders approved an amendment and restatement of the eHealth, Inc. Amended and Restated 2024 Equity Incentive Plan (as amended and restated, the “2024 Amended Equity Plan”) to increase the maximum number of shares that may be issued by 1,300,000 shares. A summary description of the 2024 Amended Equity Plan is set forth in the Company's definitive proxy statement filed with the U.S. Securities and Exchange Commission on April 28, 2026 (the "Proxy Statement") and is qualified in its entirety by reference to the full text of the 2024 Amended Equity Plan, a copy of which is filed as Exhibit 10.1 to this Form 8-K.

Item 5.07Submission of Matters to a Vote of Security Holders.

As of the close of business on April 20, 2026, the record date for the Annual Meeting, the holders of the Company’s capital stock were entitled to an aggregate of 35,958,616 votes, comprised of (i) an aggregate of 31,532,924 votes to which the holders of the Company’s 31,532,924 shares of outstanding common stock were entitled and (ii) 4,425,692 votes to which the holder of all of the Company’s 2,250,000 shares of outstanding Series A preferred stock was entitled. An aggregate of 29,916,794 votes were represented at the Annual Meeting, or 83.19% of the total voting power of the shares of the Company’s capital stock entitled to vote.

Summarized below are the final voting results for each proposal submitted to a vote of the stockholders at the Annual Meeting:

Proposal 1 – Election of Directors. The Company’s stockholders voted to elect two Class II directors (Prama Bhatt and Beth A. Brooke) to serve for terms of three years and until their respective successors are duly elected and qualified, subject to earlier resignation or removal, with voting results as follows:

NameVotes ForVotes WithheldBroker Non-Votes
Prama Bhatt18,471,6332,729,7488,715,413
Beth A. Brooke17,453,0213,748,3608,715,413

Proposal 2 – Ratification of the Appointment of Independent Registered Public Accounting Firm. The Company’s stockholders voted to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026, with voting results as follows:

Votes ForVotes AgainstAbstain
28,357,14143,0171,516,636

Proposal 3 – A Vote to Approve, on an Advisory Basis, the Compensation of the Company’s Named Executive Officers. The Company’s stockholders voted to approve the compensation of the Company’s named executive officers as described in the Proxy Statement, with voting results as follows:

Votes ForVotes AgainstAbstainBroker Non-Votes
18,199,2381,375,7031,626,4408,715,413

Proposal 4 – A Vote to Approve an Amendment and Restatement of the Amended and Restated 2024 Equity Incentive Plan. The Company’s stockholders voted to approve the amendment and restatement of the Company’s Amended and Restated 2024 Equity Incentive Plan to increase the maximum number of shares of common stock that may be issued thereunder by 1,300,000 shares, with voting results as follows:

Votes ForVotes AgainstAbstainBroker Non-Votes
16,122,5733,457,0221,621,7868,715,413

Item 9.01 Financial Statements and Exhibits.

(d)    Exhibits

Exhibit No.Description
10.1*Amended and Restated 2024 Equity Incentive Plan

104Cover Page Interactive Data File (embedded within the Inline XBRL document)

*     Indicates a management contract or compensatory plan or arrangement.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

eHealth, Inc.
Date:June 25, 2026/s/ Gavin G. Galimi
Gavin G. Galimi
SVP, General Counsel and Corporate Secretary